A Filipino-Israeli pharmaceutical company looks to invest more than P1 billion to produce a Covid-19 oral vaccine in the country, the Philippine Economic Zone Authority (PEZA) said on Thursday.
In a Viber message, PEZA Director General Charito Plaza told The Manila Times that the “estimated initial capital investment is P1.4 billion,” and said the firm targeted to establish a facility for it at the Pampanga Economic Zone.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.